Results 311 to 315 of about 447,577 (315)

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC

Nature Reviews Clinical Oncology, 2009
Nicola Normanno, Sabine Tejpar, Floriana Morgillo   +2 more
exaly  

Aumolertinib with carboplatin–pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open‐label, multicenter, randomized phase 3 study

Ca-A Cancer Journal for Clinicians
Da-Xing Zhu
exaly  

Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer

Oncogene, 2009
Marileila Varella-Garcia, Federico Cappuzzo, Cappuzzo F   +2 more
exaly  

EGFR-activated myofibroblasts promote metastasis of pancreatic cancer

Cancer Cell
Giulia Biffi
exaly  

EGFR

openaire   +1 more source